AAAAAA
Results:
1-8
|
Results: 8
Authors:
Ogra, PL
Faden, H
Welliver, RC
Citation: Pl. Ogra et al., Vaccination strategies for mucosal immune responses (vol 14, pg 430, 2001), CLIN MICROB, 14(3), 2001, pp. 641-641
Authors:
Ogra, PL
Faden, H
Welliver, RC
Citation: Pl. Ogra et al., Vaccination strategies for mucosal immune responses, CLIN MICROB, 14(2), 2001, pp. 430
Authors:
Freihorst, J
Ogra, PL
Citation: J. Freihorst et Pl. Ogra, Mucosal immunity and viral infections, ANN MED, 33(3), 2001, pp. 172-177
Authors:
Garofalo, RP
Patti, J
Hintz, KA
Hill, V
Ogra, PL
Welliver, RC
Citation: Rp. Garofalo et al., Macrophage inflammatory protein-1 alpha (not T helper type 2 cytokines) isassociated with severe forms of respiratory syncytial virus bronchiolitis, J INFEC DIS, 184(4), 2001, pp. 393-399
Authors:
Ogra, PL
Citation: Pl. Ogra, From chimpanzee coryza to palivizumab: changing times for respiratory syncytial virus, PEDIAT INF, 19(8), 2000, pp. 774-779
Authors:
Ramilo, O
Ogra, PL
Welliver, RC
DeVincenzo, JP
Sanchez, PJ
Piedra, PA
McCracken, GH
Citation: O. Ramilo et al., Respiratory syncytial virus: future challenges. Panel discussion, PEDIAT INF, 19(8), 2000, pp. 811-813
Authors:
Ogra, PL
Citation: Pl. Ogra, Mucosal immune response in the ear, nose and throat, PEDIAT INF, 19(5), 2000, pp. S4-S8
Authors:
Ogra, PL
Citation: Pl. Ogra, Poliomyelitis as a paradigm for investment in and success of vaccination programs, PEDIAT INF, 18(1), 1999, pp. 10-15
Risultati:
1-8
|